Skip to main content

Want a detailed portfolio tracker?

Adial Pharmaceuticals (ADIL) P/E (2018 - 2026)

Adial Pharmaceuticals (ADIL) P/E from Jul 27, 2018 to Jul 21, 2026. The TTM Adial Pharmaceuticals (ADIL) P/E is -2.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Adial Pharmaceuticals (ADIL)

YearP/EChange
2026-2.05-33.00%
2025-3.06-3.29%
2024-3.16-254.58%
20232.04-119.12%
2022-10.69-92.04%
2021-134.26+58.82%
2020-84.53-29.46%
2019-119.84-52.93%
2018-254.59N/A

Comparison Adial Pharmaceuticals (ADIL) P/E with competitors

Adial Pharmaceuticals (ADIL) P/E is -2.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.21%
ENLVEnlivex Ltd0.07-103.65%
FGENFibroGen Inc0.24-111.73%
CHRSCoherus Biosciences Inc0.85-141.45%
FBIOFortress Biotech Inc0.95-146.36%
ORMPOramed Pharmaceuticals Inc1.50-173.42%
AGENAgenus Inc3.01-247.01%
INVAInnoviva Inc3.15-254.06%
VXRTVaxart Inc3.55-273.39%
CRMDCorMedix Inc3.63-277.24%
CVACCureVac N.V.4.45-317.16%
GLPGGalapagos NV4.86-337.34%
SRPTSarepta Therapeutics Inc4.88-338.48%
ABEOAbeona Therapeutics Inc5.39-363.16%
ABUSArbutus Biopharma Corp5.60-373.33%
ZVRAZevra Therapeutics Inc5.89-387.57%
SPROSpero Therapeutics Inc6.23-404.24%
CGENCompugen Ltd6.31-408.42%
RIGLRigel Pharmaceuticals6.87-435.68%
SLXNSilexion Therapeutics Corp7.30-456.39%
OMEROmeros Corporation9.26-552.26%
AUPHAurinia Pharmaceuticals Inc9.58-568.20%
PLXProtalix BioTherapeutics Inc10.89-631.99%
ACADAcadia Pharmaceuticals Inc11.73-672.90%
TBPHTheravance Biopharma Inc12.26-698.97%
HRMYHarmony Biosciences Holdings Inc13.82-775.08%
SABSSAB Biotherapeutics Inc14.14-790.51%
NAGENiagen Bioscience Inc14.82-823.82%
INCYIncyte Corp15.82-872.89%
REGNRegeneron Pharmaceuticals Inc15.86-874.55%
PBYIPuma Biotechnology Inc17.32-945.82%
CPRXCatalyst Pharmaceuticals Inc17.44-951.86%
EXELExelixis Inc17.54-956.68%
TGTXTG Therapeutics Inc18.97-1026.44%
MDXGMimedx Group Inc20.55-1103.93%
XOMAXOMA Royalty Corp22.87-1217.39%
ARGXArgen X SE24.30-1286.92%
CTMXCytomX Therapeutics Inc24.82-1312.47%
XOMAOXOMA Royalty Corp25.34-1338.05%
HALOHalozyme Therapeutics Inc25.62-1351.68%
XOMAPXOMA Royalty Corp25.67-1353.94%
VRTXVertex Pharmaceuticals Inc27.99-1467.50%
RPRXRoyalty Pharma plc - Class A28.69-1501.34%
SLNOSoleno Therapeutics Inc29.02-1517.35%
ASNDAscendis Pharma A/S30.09-1569.63%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1951.94%
APLSApellis Pharmaceuticals Inc39.02-2006.12%
BMRNBiomarin Pharmaceutical Inc42.21-2161.98%
KRYSKrystal Biotech Inc45.34-2314.96%
ONCBeiGene Ltd69.54-3496.94%
PHARPharming Group N.V.75.03-3764.88%
TECHBio-Techne Corp101.96-5080.51%
VCELVericel Corp109.92-5469.49%
ALNYAlnylam Pharmaceuticals Inc117.96-5862.41%
GMABGenmab140.29-6952.99%
TLXTelix Pharmaceuticals Ltd162.15-8020.91%
CORTCorcept Therapeutics Inc212.86-10497.76%